HomeInsights52 Week High Stocks

Alembic Pharmaceuticals Ltd 52 Week High

Alembic Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.8 Cr

Volume transacted

stocks purchased

7.1 K

stocks traded

Last Updated time: 04 Nov 15:30 PM

Image

Alembic Pharmaceuticals Ltd

NSE: APLLTD

YEARHIGH

1296.15

Last updated on: Nov 01, 2024

Key Highlights

  • The 52 Week HIGH of Alembic Pharmaceuticals Ltd is ₹ 1296 as of 01 Nov 24.

Company Fundamentals for Alembic Pharmaceuticals Ltd

No data available

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Alembic Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
01 Nov 20241121.4
31 Oct 20241128.75
30 Oct 20241083.3
29 Oct 20241061.6
28 Oct 20241074.2
25 Oct 20241068.5
24 Oct 20241066.8
23 Oct 20241085.35
22 Oct 20241090.7
21 Oct 20241141.1

Asset Value vs Market Value of Alembic Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Alembic Pharmaceuticals Ltd

No data available

* All values are in crore

Alembic Pharmaceuticals Ltd News Hub

News

Alembic Pharma gets USFDA nod for hypertension treatment drug

The said drug is therapeutically equivalent to the reference listed drug product (RLD), Di...

Read more

21 Oct 202411:23

News

Alembic Pharmaceuticals to discuss results

Alembic Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 ...

Read more

18 Oct 202417:20

News

Alembic Pharma's oncology formulations unit successfully completes USFDA inspection

Alembic Pharmaceuticals has successfully completed the United States Food and Drug Adminis...

Read more

09 Oct 202409:16

News

Alembic Pharma rises after oncology facility completes US FDA audit with 'zero' observations

The US FDA had conducted an inspection at the company's oncology (injectable and oral soli...

Read more

09 Oct 202409:21

News

Alembic Pharma gets US FDA nod for antihistamine Alcaftadine ophthalmic solution

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD)...

Read more

04 Oct 202409:29

News

Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration...

Read more

03 Oct 202409:23

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for 52 Week High of Alembic Pharmaceuticals Ltd

What is the significance of Alembic Pharmaceuticals Ltd reaching its 52-week high?

Alembic Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Alembic Pharmaceuticals Ltd 52-week high?

Investors monitor Alembic Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Alembic Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Alembic Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Alembic Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Alembic Pharmaceuticals Ltd at its 52-week high?

Before investing in Alembic Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Alembic Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Alembic Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*